ASX - By Stock
|
NOX |
FDA Emergency Use Authorization (EUA)
|
|
Stayso 54
|
8 |
3.0K |
9 |
28/04/20 |
28/04/20 |
ASX - By Stock
|
8
|
3.0K
|
9
|
|
ASX - By Stock
|
NOX |
Re:
The Big Picture
|
|
Stayso 54
|
2 |
1.1K |
4 |
17/04/20 |
17/04/20 |
ASX - By Stock
|
2
|
1.1K
|
4
|
|
ASX - By Stock
|
NOX |
Re:
News: NOX Noxopharm Proposes To Evaluate Idronoxil Use In Patients
|
|
Stayso 54
|
3 |
2.1K |
6 |
01/04/20 |
01/04/20 |
ASX - By Stock
|
3
|
2.1K
|
6
|
|
ASX - By Stock
|
NOX |
Re:
News: NOX Noxopharm Proposes To Evaluate Idronoxil Use In Patients
|
|
Stayso 54
|
3 |
2.1K |
8 |
01/04/20 |
01/04/20 |
ASX - By Stock
|
3
|
2.1K
|
8
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Veyonda Awarded First Allowed Patent Application
|
|
Stayso 54
|
13 |
6.8K |
2 |
17/03/20 |
17/03/20 |
ASX - By Stock
|
13
|
6.8K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Half Year Accounts and Chairman Letter
|
|
Stayso 54
|
24 |
724K |
8 |
07/03/20 |
07/03/20 |
ASX - By Stock
|
24
|
724K
|
8
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Half Year Accounts and Chairman Letter
|
|
Stayso 54
|
24 |
724K |
1 |
03/03/20 |
03/03/20 |
ASX - By Stock
|
24
|
724K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Half Year Accounts and Chairman Letter
|
|
Stayso 54
|
24 |
724K |
2 |
01/03/20 |
01/03/20 |
ASX - By Stock
|
24
|
724K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Half Year Accounts and Chairman Letter
|
|
Stayso 54
|
24 |
724K |
0 |
29/02/20 |
29/02/20 |
ASX - By Stock
|
24
|
724K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Half Year Accounts and Chairman Letter
|
|
Stayso 54
|
24 |
724K |
1 |
27/02/20 |
27/02/20 |
ASX - By Stock
|
24
|
724K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Half Year Accounts and Chairman Letter
|
|
Stayso 54
|
24 |
724K |
5 |
27/02/20 |
27/02/20 |
ASX - By Stock
|
24
|
724K
|
5
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Trading Halt
|
|
Stayso 54
|
11 |
6.5K |
0 |
12/02/20 |
12/02/20 |
ASX - By Stock
|
11
|
6.5K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Noxopharm Corporate Presentation (January)
|
|
Stayso 54
|
11 |
5.7K |
3 |
22/01/20 |
22/01/20 |
ASX - By Stock
|
11
|
5.7K
|
3
|
|
ASX - By Stock
|
NOX |
Noxopharm Corporate Presentation (January)
|
|
Stayso 54
|
11 |
5.7K |
3 |
16/01/20 |
16/01/20 |
ASX - By Stock
|
11
|
5.7K
|
3
|
|
ASX - By Stock
|
NOX |
Re:
Inexplicable
|
|
Stayso 54
|
4 |
3.3K |
0 |
31/12/19 |
31/12/19 |
ASX - By Stock
|
4
|
3.3K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Positive DARRT-1 Data in Late-Stage Prostate Cancer
|
|
Stayso 54
|
29 |
14K |
2 |
12/12/19 |
12/12/19 |
ASX - By Stock
|
29
|
14K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Positive DARRT-1 Data in Late-Stage Prostate Cancer
|
|
Stayso 54
|
29 |
14K |
4 |
11/12/19 |
11/12/19 |
ASX - By Stock
|
29
|
14K
|
4
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Positive DARRT-1 Data in Late-Stage Prostate Cancer
|
|
Stayso 54
|
29 |
14K |
8 |
10/12/19 |
10/12/19 |
ASX - By Stock
|
29
|
14K
|
8
|
|
ASX - By Stock
|
NOX |
Re:
FNN Interview
|
|
Stayso 54
|
2 |
1.0K |
6 |
04/12/19 |
04/12/19 |
ASX - By Stock
|
2
|
1.0K
|
6
|
|
ASX - By Stock
|
NOX |
FNN Interview
|
|
Stayso 54
|
2 |
1.0K |
4 |
04/12/19 |
04/12/19 |
ASX - By Stock
|
2
|
1.0K
|
4
|
|
ASX - By Stock
|
NOX |
2019 AGM Webcast
|
|
Stayso 54
|
0 |
268 |
4 |
29/11/19 |
29/11/19 |
ASX - By Stock
|
0
|
268
|
4
|
|
ASX - By Stock
|
NOX |
Re:
Don’t Miss the AGM. 20 November!!
|
|
Stayso 54
|
2 |
1.4K |
1 |
17/11/19 |
17/11/19 |
ASX - By Stock
|
2
|
1.4K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Don’t Miss the AGM. 20 November!!
|
|
Stayso 54
|
2 |
1.4K |
0 |
17/11/19 |
17/11/19 |
ASX - By Stock
|
2
|
1.4K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: NOX and Nyrada TechKnow Invest Roadshow Presentations
|
|
Stayso 54
|
4 |
3.0K |
2 |
29/10/19 |
29/10/19 |
ASX - By Stock
|
4
|
3.0K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Further Review Shows Major Clinical Benefits from Veyonda
|
|
Stayso 54
|
6 |
3.6K |
3 |
30/09/19 |
30/09/19 |
ASX - By Stock
|
6
|
3.6K
|
3
|
|
ASX - By Stock
|
NOX |
Re:
Patent update
|
|
Stayso 54
|
16 |
7.2K |
3 |
27/09/19 |
27/09/19 |
ASX - By Stock
|
16
|
7.2K
|
3
|
|
ASX - By Stock
|
NOX |
Re:
Patent update
|
|
Stayso 54
|
16 |
7.2K |
4 |
27/09/19 |
27/09/19 |
ASX - By Stock
|
16
|
7.2K
|
4
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Annual Report to Shareholders
|
|
Stayso 54
|
13 |
5.3K |
2 |
26/09/19 |
26/09/19 |
ASX - By Stock
|
13
|
5.3K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Annual Report to Shareholders
|
|
Stayso 54
|
13 |
5.3K |
2 |
26/09/19 |
26/09/19 |
ASX - By Stock
|
13
|
5.3K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Annual Report to Shareholders
|
|
Stayso 54
|
13 |
5.3K |
1 |
26/09/19 |
26/09/19 |
ASX - By Stock
|
13
|
5.3K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
EGM
|
|
Stayso 54
|
4 |
3.3K |
5 |
17/09/19 |
17/09/19 |
ASX - By Stock
|
4
|
3.3K
|
5
|
|
ASX - By Stock
|
NOX |
Re:
An Investment in Biotech: Part 3
|
|
Stayso 54
|
4 |
1.7K |
3 |
11/09/19 |
11/09/19 |
ASX - By Stock
|
4
|
1.7K
|
3
|
|
ASX - By Stock
|
NOX |
An Investment in Biotech: Part 3
|
|
Stayso 54
|
4 |
1.7K |
5 |
11/09/19 |
11/09/19 |
ASX - By Stock
|
4
|
1.7K
|
5
|
|
ASX - By Stock
|
NOX |
Re:
No need to panic
|
|
Stayso 54
|
7 |
4.3K |
5 |
30/08/19 |
30/08/19 |
ASX - By Stock
|
7
|
4.3K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Ann: WHO selects provisional name for Kazia's GDC-0084
|
|
Stayso 54
|
20 |
6.9K |
3 |
24/08/19 |
24/08/19 |
ASX - By Stock
|
20
|
6.9K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Ann: WHO selects provisional name for Kazia's GDC-0084
|
|
Stayso 54
|
20 |
6.9K |
2 |
23/08/19 |
23/08/19 |
ASX - By Stock
|
20
|
6.9K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Patent Update
|
|
Stayso 54
|
3 |
2.3K |
5 |
15/08/19 |
15/08/19 |
ASX - By Stock
|
3
|
2.3K
|
5
|
|
ASX - By Stock
|
NOX |
Re:
Market valuation.
|
|
Stayso 54
|
15 |
3.6K |
1 |
13/08/19 |
13/08/19 |
ASX - By Stock
|
15
|
3.6K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Market valuation.
|
|
Stayso 54
|
15 |
3.6K |
4 |
13/08/19 |
13/08/19 |
ASX - By Stock
|
15
|
3.6K
|
4
|
|
ASX - By Stock
|
NOX |
Re:
Funding Facility
|
|
Stayso 54
|
38 |
11K |
4 |
08/08/19 |
08/08/19 |
ASX - By Stock
|
38
|
11K
|
4
|
|
ASX - By Stock
|
NOX |
Re:
Funding Facility
|
|
Stayso 54
|
38 |
11K |
4 |
01/08/19 |
01/08/19 |
ASX - By Stock
|
38
|
11K
|
4
|
|
ASX - By Stock
|
NOX |
Re:
Disinformation
|
|
Stayso 54
|
22 |
9.9K |
7 |
31/07/19 |
31/07/19 |
ASX - By Stock
|
22
|
9.9K
|
7
|
|
ASX - By Stock
|
NOX |
Re:
Disinformation
|
|
Stayso 54
|
22 |
9.9K |
3 |
30/07/19 |
30/07/19 |
ASX - By Stock
|
22
|
9.9K
|
3
|
|
ASX - By Stock
|
NOX |
Re:
St Vincent’s Hospital LUPIN Study PR
|
|
Stayso 54
|
33 |
16K |
3 |
26/07/19 |
26/07/19 |
ASX - By Stock
|
33
|
16K
|
3
|
|
ASX - By Stock
|
NOX |
Re:
St Vincent’s Hospital LUPIN Study PR
|
|
Stayso 54
|
33 |
16K |
2 |
25/07/19 |
25/07/19 |
ASX - By Stock
|
33
|
16K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
St Vincent’s Hospital LUPIN Study PR
|
|
Stayso 54
|
33 |
16K |
4 |
24/07/19 |
24/07/19 |
ASX - By Stock
|
33
|
16K
|
4
|
|
ASX - By Stock
|
NOX |
Re:
St Vincent’s Hospital LUPIN Study PR
|
|
Stayso 54
|
33 |
16K |
5 |
24/07/19 |
24/07/19 |
ASX - By Stock
|
33
|
16K
|
5
|
|
ASX - By Stock
|
NOX |
Re:
Funding Facility
|
|
Stayso 54
|
38 |
11K |
6 |
23/07/19 |
23/07/19 |
ASX - By Stock
|
38
|
11K
|
6
|
|
ASX - By Stock
|
NOX |
Re:
Mergers and Acquisitions
|
|
Stayso 54
|
30 |
13K |
2 |
17/07/19 |
17/07/19 |
ASX - By Stock
|
30
|
13K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Versatility Newsletter
|
|
Stayso 54
|
3 |
1.3K |
1 |
17/07/19 |
17/07/19 |
ASX - By Stock
|
3
|
1.3K
|
1
|
|